Safety and Activity of Varlilumab, a Novel and First-in-Class Agonist Anti-CD27 Antibody, in Patients With Advanced Solid Tumors (Q30252469)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Safety and Activity of Varlilumab, a Novel and First-in-Class Agonist Anti-CD27 Antibody, in Patients With Advanced Solid Tumors |
scientific article |
Statements
1 reference
Safety and Activity of Varlilumab, a Novel and First-in-Class Agonist Anti-CD27 Antibody, in Patients With Advanced Solid Tumors (English)
1 reference
Branimir I Sikic
1 reference
Donald W Northfelt
1 reference
Howard A Burris
1 reference
Jeffrey R Infante
1 reference
Stephen M Ansell
1 reference
John J Nemunaitis
1 reference
Geoffrey R Weiss
1 reference
Victor M Villalobos
1 reference
Matthew H Taylor
1 reference
William E Carson
1 reference
Thomas R Hawthorne
1 reference
Thomas A Davis
1 reference
Michael J Yellin
1 reference
Tibor Keler
1 reference
Timothy Bullock
1 reference
1 reference
Identifiers
1 reference